Page 25 - 《中国药房》2023年24期

129-143. [25] BJÖRCK M，KOELEMAY M，ACOSTA S，et al. Editor’s
[14] European Association for the Study of the Liver. EASL choice： management of the diseases of mesenteric arteries
clinical practice guidelines：vascular diseases of the liver and veins：clinical practice guidelines of the European So‐
[J]. J Hepatol，2016，64（1）：179-202. ciety of Vascular Surgery（ESVS）[J]. Eur J Vasc Endovasc
[15] NORTHUP P G，GARCIA-PAGAN J C，GARCIA-TSAO Surg，2017，53（4）：460-510.
G，et al. Vascular liver disorders，portal vein thrombosis， [26] 中国医师协会急诊医师分会，解放军急救医学专业委员
and procedural bleeding in patients with liver disease： 会，中华医学会急诊医学分会，等 . 2020 年中国急性肠
2020 practice guidance by the American Association for 系膜缺血诊断与治疗专家共识[J]. 中华急诊医学杂志，
the Study of Liver Diseases[J]. Hepatology，2021，73（1）： 2020，29（10）：1273-1281.
366-413. Emergency Physicians Branch of the Chinese Medical
[16] SIMONETTO D A，SINGAL A K，GARCIA-TSAO G，et Doctor Association，PLA Emergency Medicine Profes‐
al. ACG clinical guideline：disorders of the hepatic and sional Committee， Emergency Medicine Branch of
mesenteric circulation[J]. Am J Gastroenterol，2020，115 Chinese Medical Association，et al. Expert consensus on
（1）：18-40. diagnosis and treatment of acute mesenteric ischemia in
[17] 中华医学会消化病学分会肝胆疾病学组. 肝硬化门静脉 China of 2020[J]. Chin J Emerg Med，2020，29（10）：1273-
血栓管理专家共识：2020年，上海[J]. 中华肝脏病杂志， 1281.
2020，28（12）：999-1007. [27] BALA M，CATENA F，KASHUK J，et al. Acute mesen‐
Hepatobiliary Disease Study Group，Chinese Society of teric ischemia：updated guidelines of the World Society of
Gastroenterology，Chinese Medical Association. Consen‐ Emergency Surgery[J]. World J Emerg Surg，2022，
sus for management of portal vein thrombosis in liver cir‐ 17（1）：54.
rhosis：2020，Shanghai[J]. Chin J Hepatol，2020，28（12）： [28] SALIM S，ZARROUK M，ELF J，et al. Improved progno‐
999-1007. sis and low failure rate with anticoagulation as first-line
[18] LOFFREDO L，PASTORI D，FARCOMENI A，et al. Ef‐ therapy in mesenteric venous thrombosis[J]. World J Surg，
fects of anticoagulants in patients with cirrhosis and portal 2018，42（11）：3803-3811.
vein thrombosis：a systematic review and meta-analysis [29] AGENO W，RIVA N，SCHULMAN S，et al. Long-term
[J]. Gastroenterology，2017，153（2）：480-487.e1. clinical outcomes of splanchnic vein thrombosis：results of
[19] YAO C，ZHAO M，IBRAHIM B，et al. Anticoagulation an international registry[J]. JAMA Intern Med，2015，175
for the treatment of portal vein thrombosis in cirrhosis：a （9）：1474-1480.
systematic review and meta-analysis of comparative stu- [30] JOH J H，KIM D I. Mesenteric and portal vein thrombo‐
dies[J]. J Clin Exp Hepatol，2023，13（3）：404-413. sis：treated with early initiation of anticoagulation[J]. Eur
[20] ZHANG Z H，ZHANG J W，HE P，et al. Fondaparinux is J Vasc Endovasc Surg，2005，29（2）：204-208.
effective for acute portal vein thrombosis in decompen‐ [31] FERRO J M，BOUSSER M G，CANHÃO P，et al.
sated cirrhotic patients[J]. Medicine，2017，96（42）：e8256. European Stroke Organization guideline for the diagnosis
[21] SENZOLO M，PIANO S，SHALABY S，et al. Compari‐ and treatment of cerebral venous thrombosis：endorsed by
son of fondaparinux and low-molecular-weight heparin in the European Academy of Neurology[J]. Eur Stroke J，
the treatment of portal vein thrombosis in cirrhosis[J]. Am 2017，2（3）：195-221.
J Med，2021，134（10）：1278-1285.e2. [32] 中华医学会神经病学分会，中华医学会神经病学分会脑
[22] NAYMAGON L，TREMBLAY D，ZUBIZARRETA N，et 血管病学组 . 中国颅内静脉血栓形成诊断和治疗指南
al. The efficacy and safety of direct oral anticoagulants in 2019[J]. 中华神经科杂志，2020，53（9）：648-663.
noncirrhotic portal vein thrombosis[J]. Blood Adv，2020，4 Chinese Society of Neurology，Group of Cerebrovascular
（4）：655-666. Diseases of Chinese Society of Neurology. Chinese guide‐
[23] KOH J H，LIEW Z H，NG G K，et al. Efficacy and safety lines for diagnosis and treatment of cerebral venous throm‐
of direct oral anticoagulants versus vitamin K antagonist bosis 2019[J]. Chin J Neurol，2020，53（9）：648-663.
for portal vein thrombosis in cirrhosis：a systematic re‐ [33] COUTINHO J M，FERRO J M，CANHÃO P，et al. Un‐
view and meta-analysis[J]. Dig Liver Dis，2022，54（1）： fractionated or low-molecular weight heparin for the treat‐
56-62. ment of cerebral venous thrombosis[J]. Stroke，2010，41
[24] TILSED J V，CASAMASSIMA A，KURIHARA H，et al. （11）：2575-2580.
ESTES guidelines：acute mesenteric ischaemia[J]. Eur J [34] MISRA U K，KALITA J，CHANDRA S，et al. Low mo‐
Trauma Emerg Surg，2016，42（2）：253-270. lecular weight heparin versus unfractionated heparin in ce‐

中国药房 2023年第34卷第24期 China Pharmacy 2023 Vol. 34 No. 24 · 2963 ·